Skip to content

Clinical trials

Enrolling by invitation Scleroderma, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Enrolling by invitation Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20231
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pamukkale University2
Adicet Therapeutics1
Bioray Laboratories1
Kite, A Gilead Company1
National Institute of Blood and Marrow Transplant (NIBMT), Pakistan1
Peking University People's Hospital1
Royal Brompton & Harefield NHS Foundation Trust1
Turku University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic9
Lupus Erythematosus, Systemic4
Myositis4
Autoimmune Diseases3
Arthritis, Rheumatoid2
Lupus Nephritis2
Spondylitis, Ankylosing2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Antiphospholipid Syndrome1
Arthritis, Gouty1

Trials

Showing 26 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.